Published in N Engl J Med on September 20, 2001
Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect (2005) 2.29
Kidney proximal tubular epithelial-specific overexpression of netrin-1 suppresses inflammation and albuminuria through suppression of COX-2-mediated PGE2 production in streptozotocin-induced diabetic mice. Am J Pathol (2012) 1.69
Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med (2004) 1.05
Inflammatory cytokines in diabetic nephropathy. J Diabetes Res (2015) 1.01
Inflammation in diabetic kidney disease. World J Diabetes (2014) 0.91
Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis. J Am Soc Nephrol (2015) 0.87
Urinary semaphorin 3A correlates with diabetic proteinuria and mediates diabetic nephropathy and associated inflammation in mice. J Mol Med (Berl) (2014) 0.85
Ethnicity and attitudes to deceased kidney donation: a survey in Barbados and comparison with Black Caribbean people in the United Kingdom. BMC Public Health (2010) 0.82
Tubular injury marker netrin-1 is elevated early in experimental diabetes. J Nephrol (2013) 0.81
Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases. Recent Pat Biomark (2012) 0.81
National Kidney Disease Education Program. J Natl Med Assoc (2002) 0.80
Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus. Medicine (Baltimore) (2015) 0.75
Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice. Am J Nephrol (2015) 0.75
Renoprotection and the Bardoxolone Methyl Story - Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents. Nephron Extra (2013) 0.75
Effect of irbesartan on streptozotocin induced diabetic nephropathy: An interventionary study. Indian J Clin Biochem (2008) 0.75
Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy. Stem Cells Int (2016) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med (2001) 10.36
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest (1985) 2.32
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Role of aldosterone in the remnant kidney model in the rat. J Clin Invest (1996) 1.65
Downloadable computer models for renal replacement therapy. Kidney Int (2006) 1.56
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Severe flank pain as the predominant symptom of IgA nephropathy. Am J Kidney Dis (1989) 1.39
Glomerular basement membrane: in vitro studies of water and protein permeability. Am J Physiol (1992) 1.36
The course of the remnant kidney model in mice. Kidney Int (1999) 1.26
Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am J Physiol (1978) 1.25
Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. J Clin Invest (1986) 1.21
Human renal response to meat meal. Am J Physiol (1986) 1.21
The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol (1997) 1.17
Oxygen consumption and oxidant stress in surviving nephrons. Am J Physiol (1990) 1.15
Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest (1993) 1.14
Compensatory renal hemodynamic injury: a final common pathway of residual nephron destruction. Am J Kidney Dis (1982) 1.10
Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res (1984) 1.08
Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury. J Clin Invest (1987) 1.08
Adverse effects of growth in the glomerular microcirculation. Am J Physiol (1990) 1.06
Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int (1986) 1.05
Effect of dietary protein on rat renin and angiotensinogen gene expression. J Clin Invest (1990) 1.02
Diabetic nephropathy. J Am Soc Nephrol (1997) 1.00
The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int (1994) 0.99
Course of renal injury in the Mpv17-deficient transgenic mouse. J Am Soc Nephrol (2000) 0.96
Treatment of hypoparathyroid patients with chlorthalidone. N Engl J Med (1978) 0.95
The role of oxidants in progressive renal injury. Kidney Int Suppl (1994) 0.92
Glomerular and hormonal responses to dietary protein intake in human renal disease. Am J Physiol (1987) 0.90
The renin-aldosterone axis in two models of reduced renal mass in the rat. J Am Soc Nephrol (1998) 0.90
Increased ammoniagenesis as a determinant of progressive renal injury. Am J Kidney Dis (1991) 0.89
The role of glomerular hyperfiltration in the initiation and progression of diabetic nephropathy. Acta Endocrinol Suppl (Copenh) (1981) 0.89
Regulatory role of prostanoids in glomerular microcirculation of remnant nephrons. Am J Physiol (1987) 0.87
Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Semin Nephrol (1997) 0.86
Glomerular renin synthesis and storage in the remnant kidney in the rat. Kidney Int (1991) 0.86
Dietary protein increases plasma renin and reduces pressor reactivity to angiotensin II. Am J Physiol (1986) 0.86
Renin expression in renal ablation. Hypertension (1992) 0.85
Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol (1983) 0.85
Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Lab Invest (1994) 0.84
Role of cellular metabolites in progressive renal injury. Kidney Int Suppl (1992) 0.83
Intrarenal distribution of clusterin following reduction of renal mass. Kidney Int (1992) 0.83
Ammonia-complement interaction in the pathogenesis of progressive renal injury. Kidney Int Suppl (1989) 0.82
Animal models of renal disease. Kidney Int (2008) 0.82
Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. J Am Soc Nephrol (1997) 0.82
Effects of dietary protein intake on vasoactive hormones. Am J Physiol (1990) 0.81
Progression of kidney disease in chronic renal transplant rejection. Transplantation (1991) 0.81
Renin and angiotensinogen gene expression in experimental diabetes mellitus. Kidney Int (1992) 0.81
Interaction of complement and clusterin in renal injury. J Am Soc Nephrol (1992) 0.81
Induction of clusterin in acute and chronic oxidative renal disease in the rat and its dissociation from cell injury. Lab Invest (1994) 0.80
Kidney complications. Diabetes (1982) 0.80
Glomerular response to renal injury. Contrib Nephrol (1982) 0.80
Effects of dietary protein in patients with chronic renal transplant rejection. Kidney Int (1992) 0.79
Role of dietary potassium in the hyperaldosteronism and hypertension of the remnant kidney model. J Am Soc Nephrol (2000) 0.79
Effect of dietary protein on the renin-angiotensin system in subtotally nephrectomized rats. Kidney Int (1990) 0.79
Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist. Am J Kidney Dis (1991) 0.79
Renal functional derangements in hypertension. Fed Proc (1986) 0.78
The hyperfiltering glomerulus. Med Clin North Am (1984) 0.78
Effect of dietary protein on renin and angiotensinogen gene expression after renal ablation. Am J Physiol (1992) 0.78
Role of ammonia in progressive interstitial nephritis. Am J Kidney Dis (1991) 0.77
Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes (1989) 0.77
Effect of angiotensin II blockade on dietary protein-induced renal growth. Am J Kidney Dis (1993) 0.76
Role of ammonia in tubulointerstitial injury. Miner Electrolyte Metab (1990) 0.76
Progressive renal disease: is the slippery slope species specific? J Lab Clin Med (1987) 0.76
Hyperosmolality impairs ammonia-mediated inflammation: implications for the renal medulla. Am J Physiol (1992) 0.75
Continuous hemofiltration. N Engl J Med (1997) 0.75
The response of erythropoietin to dietary protein in human renal disease. J Lab Clin Med (1989) 0.75
Renal microcirculation in diabetes mellitus. Acta Endocrinol Suppl (Copenh) (1981) 0.75
Response of early growth response genes to renal vasoconstriction. Exp Nephrol (1994) 0.75
Lack of dependence of urine PCO2 upon reduction of glomerular filtration rate in alkalotic dogs. Clin Sci Mol Med (1977) 0.75
Comparison of residual glomerular function in experimental papillary necrosis and renal infarction. Am J Kidney Dis (1990) 0.75
Functional and structural alterations of the glomerular permeability barrier in experimental galactosemia. Kidney Int (1991) 0.75
The role of ammonia in progressive renal injury. Contrib Nephrol (1991) 0.75
Diabetic nephropathy. N Engl J Med (1985) 0.75
Dietary protein restriction lessens the glomerular permselective defect in human renal disease. Contrib Nephrol (1988) 0.75
Mechanisms of glomerular barrier function. Contrib Nephrol (1981) 0.75
Size and disease. J Lab Clin Med (1989) 0.75
Aldosterone is a major factor in the progression of renal disease. Kidney Int Suppl (1997) 0.75
Physiological and structural responses to chronic experimental renal allograft injury. Am J Physiol (1994) 0.75
Dietary protein and the renin-angiotensin system in chronic renal allograft rejection. Kidney Int Suppl (1995) 0.75
Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. Kidney Int (1993) 0.75
Progressive glomerular injury: roles of dietary protein and compensatory hypertrophy. Pharmacol Rev (1984) 0.75
Subtotal nephrectomy in the rabbit: a model of chronic hypercalcemia, nephrolithiasis, and obstructive nephropathy. J Lab Clin Med (1986) 0.75